Jupiter Topco LLC Acquires Shares of 45,258 Encompass Health Corporation $EHC

Jupiter Topco LLC bought a new stake in shares of Encompass Health Corporation (NYSE:EHC) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 45,258 shares of the company’s stock, valued at approximately $4,577,000.

Several other institutional investors also recently modified their holdings of EHC. Persistent Asset Partners Ltd purchased a new position in Encompass Health during the 2nd quarter valued at about $36,000. Keating Financial Advisory Services Inc. purchased a new stake in Encompass Health in the second quarter worth about $39,000. Assetmark Inc. increased its stake in shares of Encompass Health by 89.6% during the first quarter. Assetmark Inc. now owns 455 shares of the company’s stock valued at $44,000 after purchasing an additional 215 shares in the last quarter. Caitong International Asset Management Co. Ltd lifted its holdings in shares of Encompass Health by 36,200.0% during the third quarter. Caitong International Asset Management Co. Ltd now owns 363 shares of the company’s stock valued at $46,000 after purchasing an additional 362 shares during the last quarter. Finally, Aster Capital Management DIFC Ltd purchased a new position in shares of Encompass Health during the fourth quarter valued at approximately $55,000. 97.25% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several research firms recently weighed in on EHC. Wall Street Zen upgraded Encompass Health from a “hold” rating to a “buy” rating in a research note on Sunday, August 16th. UBS Group lifted their price objective on Encompass Health from $150.00 to $155.00 and gave the company a “buy” rating in a research note on Friday, August 7th. TD Cowen increased their target price on Encompass Health from $125.00 to $140.00 and gave the stock a “buy” rating in a research note on Monday, August 10th. Truist Financial raised their price target on Encompass Health from $140.00 to $150.00 and gave the company a “buy” rating in a report on Friday, August 7th. Finally, Barclays lifted their price target on Encompass Health from $140.00 to $144.00 and gave the stock an “overweight” rating in a research report on Thursday, August 6th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat.com, Encompass Health presently has an average rating of “Buy” and a consensus price target of $148.71.

Insider Buying and Selling at Encompass Health

In related news, CEO Mark J. Tarr sold 173,148 shares of Encompass Health stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $125.47, for a total value of $21,724,879.56. Following the completion of the sale, the chief executive officer directly owned 267,814 shares in the company, valued at approximately $33,602,622.58. This trade represents a 39.27% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP John Patrick Darby sold 8,906 shares of the business’s stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $125.95, for a total value of $1,121,710.70. Following the completion of the transaction, the executive vice president directly owned 75,041 shares of the company’s stock, valued at approximately $9,451,413.95. This trade represents a 10.61% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 1.80% of the company’s stock.

Encompass Health Price Performance

Shares of EHC opened at $120.51 on Tuesday. The company has a market capitalization of $11.89 billion, a P/E ratio of 19.63, a price-to-earnings-growth ratio of 2.45 and a beta of 0.72. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.76. The firm has a 50 day moving average of $113.64 and a 200 day moving average of $107.27. Encompass Health Corporation has a twelve month low of $92.77 and a twelve month high of $127.99.

Encompass Health (NYSE:EHC) last released its quarterly earnings data on Wednesday, August 5th. The company reported $1.55 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.48 by $0.07. Encompass Health had a return on equity of 18.08% and a net margin of 10.01%.The business had revenue of $1.60 billion for the quarter, compared to analysts’ expectations of $1.57 billion. During the same period in the prior year, the firm posted $1.40 EPS. The firm’s quarterly revenue was up 9.6% on a year-over-year basis. Encompass Health has set its FY 2026 guidance at 6.020-6.250 EPS. As a group, equities research analysts anticipate that Encompass Health Corporation will post 6.08 earnings per share for the current fiscal year.

Encompass Health Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, October 15th. Stockholders of record on Thursday, October 1st will be issued a dividend of $0.21 per share. The ex-dividend date of this dividend is Thursday, October 1st. This is an increase from Encompass Health’s previous quarterly dividend of $0.19. This represents a $0.84 dividend on an annualized basis and a dividend yield of 0.7%. Encompass Health’s dividend payout ratio is currently 12.38%.

Encompass Health Company Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.